All Stories

  1. Mucoadhesive nanogels by ionotropic crosslinking of chitosan-g-oligo(NiPAam) polymeric micelles as novel drug nanocarriers
  2. Didanosine-loaded poly(epsilon-caprolactone) microparticles by a coaxial electrohydrodynamic atomization (CEHDA) technique
  3. Novel protease inhibitor-loaded Nanoparticle-in-Microparticle Delivery System leads to a dramatic improvement of the oral pharmacokinetics in dogs
  4. Chitosan-g-oligo(epsilon-caprolactone) polymeric micelles: microwave-assisted synthesis and physicochemical and cytocompatibility characterization
  5. Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: A review
  6. Spray-dried didanosine-loaded polymeric particles for enhanced oral bioavailability
  7. Production of Drug-Loaded Polymeric Nanoparticles by Electrospraying Technology
  8. Novel Poly(Ethylene Oxide)-b-Poly(Propylene Oxide) Copolymer-Glucose Conjugate by the Microwave-Assisted Ring Opening of a Sugar Lactone
  9. Rifampicin-loaded ‘flower-like’ polymeric micelles for enhanced oral bioavailability in an extemporaneous liquid fixed-dose combination with isoniazid
  10. Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method
  11. Encapsulation of the Antimicrobial and Immunomodulator Agent Nitazoxanide Within Polymeric Micelles
  12. Nanomedicines in the future of pediatric therapy
  13. NANOASSEMBLIES: COVALENT DERIVATIVES OF NEVIRAPINE WITH POLYETHYNE GLYCOL DIACRYLATE
  14. Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review
  15. Production of pure indinavir free base nanoparticles by a supercritical anti-solvent (SAS) method
  16. Hydrolyzed Galactomannan-Modified Nanoparticles and Flower-Like Polymeric Micelles for the Active Targeting of Rifampicin to Macrophages
  17. Temperature- and pH-sensitive Polymeric Micelles for Drug Encapsulation, Release and Targeting
  18. β-Cyclodextrin hydrogels for the ocular release of antibacterial thiosemicarbazones
  19. Nanoparticle-in-Microparticle Delivery Systems (NiMDS): Production, Administration Routes and Clinical Potential
  20. A Special Issue on Nanomedicine in Latin America
  21. Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV
  22. Poly(ɛ-caprolactone), Eudragit® RS 100 and poly(ɛ-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz
  23. Nanobiotechnology
  24. Lactosylated poly(ethylene oxide)–poly(propylene oxide) block copolymers for potential active targeting: synthesis and physicochemical and self-aggregation characterization
  25. Micro/Nanostructured Hyaluronic Acid Matrices with Tuned Swelling and Drug Release Properties
  26. Downregulation of mdr1 and abcg2 genes is a mechanism of inhibition of efflux pumps mediated by polymeric amphiphiles
  27. Antiviral activity against the hepatitis C virus (HCV) of 1-indanone thiosemicarbazones and their inclusion complexes with hydroxypropyl-β-cyclodextrin
  28. Photodynamic Effects of Zinc(II) Phthalocyanine‐Loaded Polymeric Micelles in Human Nasopharynx KB Carcinoma Cells
  29. Single and mixed poloxamine micelles as nanocarriers for solubilization and sustained release of ethoxzolamide for topical glaucoma therapy
  30. Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases
  31. Chitosan and Chitosan Derivatives for Biological Applications: Chemistry and Functionalization
  32. Efavirenz is a substrate and in turn modulates the expression of the efflux transporter ABCG2/BCRP in the gastrointestinal tract of the rat
  33. Novel 1-indanone Thiosemicarbazone Antiviral Candidates: Aqueous Solubilization and Physical Stabilization by Means of Cyclodextrins
  34. Chitosan-Grafted Copolymers and Chitosan-Ligand Conjugates as Matrices for Pulmonary Drug Delivery
  35. Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine/poloxamer polymeric micelles
  36. Cryoprotection-lyophilization and physical stabilization of rifampicin-loaded flower-like polymeric micelles
  37. Microwave-assisted polymer synthesis (MAPS) as a tool in biomaterials science: How new and how powerful
  38. PEO-PPO Block Copolymers for Passive Micellar Targeting and Overcoming Multidrug Resistance in Cancer Therapy
  39. Poloxamines Display a Multiple Inhibitory Activity of ATP-Binding Cassette (ABC) Transporters in Cancer Cell Lines
  40. ChemInform Abstract: Hydrogels with Cyclodextrins as Highly Versatile Drug Delivery Systems
  41. Fast and efficient synthesis of high molecular weight poly(epsilon‐caprolactone) diols by microwave‐assisted polymer synthesis
  42. Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles
  43. Inhibition of P-glycoprotein pumps by PEO–PPO amphiphiles: branched versus linear derivatives
  44. N-alkylation of poloxamines modulates micellar assembly and encapsulation and release of the antiretroviral efavirenz
  45. Molecular implications in the nanoencapsulation of the anti-tuberculosis drug rifampicin within flower-like polymeric micelles
  46. Nanotechnology contributions to the pharmacotherapy of pediatric HIV: a dual scientific and ethical challenge and a still pending agenda
  47. Development and Preclinical Evaluation of Acellular Collagen Scaffolding and Autologous Artificial Connective Tissue in the Regeneration of Oral Mucosa Wounds
  48. A Highly Concentrated and Taste-Improved Aqueous Formulation of Efavirenz for a More Appropriate Pediatric Management of the Anti-HIV Therapy
  49. Episcleral Implants for Topotecan Delivery to the Posterior Segment of the Eye
  50. Drug Delivery Systems and Liver Targeting for the Improved Pharmacotherapy of the Hepatitis B Virus (HBV) Infection
  51. Nanotechnology solutions for infectious diseases in developing nations
  52. New old challenges in tuberculosis: Potentially effective nanotechnologies in drug delivery
  53. Repair of Bone Defect Using Bone Marrow Cells and Demineralized Bone Matrix Supplemented with Polymeric Materials
  54. Novel long-term anticonvulsant treatment with gabapentin without causing memory impairment in mice
  55. Self-aggregation behaviour of novel thiosemicarbazone drug candidates with potential antiviral activity
  56. Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability
  57. Solution Thermodynamics of Triclocarban in Organic Solvents of Different Hydrogen Bonding Capability
  58. Drug delivery systems in HIV pharmacotherapy: What has been done and the challenges standing ahead
  59. Indinavir-Loaded pH-Sensitive Microparticles for Taste Masking: Toward Extemporaneous Pediatric Anti-HIV/AIDS Liquid Formulations with Improved Patient Compliance
  60. Poloxamine Hydrogels: from low Cell Adhesion Substrates to Matrices with Improved Cytocompatibility for Tissue Engineering Applications
  61. Solubility of the Antimicrobial Agent Triclosan in Organic Solvents of Different Hydrogen Bonding Capabilities at Several Temperatures
  62. In vitro/in vivo characterization of melt-molded gabapentin-loaded poly(epsilon-caprolactone) implants for sustained release in animal studies
  63. Self-Associative Behavior and Drug-Solubilizing Ability of Poloxamine (Tetronic) Block Copolymers
  64. Triclosan-loaded poloxamine micelles for enhanced topical antibacterial activity against biofilm
  65. Polymeric Nanocarriers: New Endeavors for the Optimization of the Technological Aspects of Drugs
  66. Entalpía de disolución de sulfacetamida sódica en agua: comparación entre la calorimetría isoperibólica de solución y el método de van't Hoff
  67. Lactoyl‐poloxamine/collagen matrix for cell‐containing tissue engineering modules
  68. Chain extension as a strategy for the development of improved reverse thermo‐responsive polymers
  69. Poly(ethylene oxide)–poly(propylene oxide) block copolymer micelles as drug delivery agents: Improved hydrosolubility, stability and bioavailability of drugs
  70. Surface study of collagen/poloxamine hydrogels by a ‘deep freezing’ ToF-SIMS approach
  71. PEO–PPO–PEO-based poly(ether ester urethane)s as degradable reverse thermo-responsive multiblock copolymers
  72. Semi-synthetic collagen/poloxamine matrices for tissue engineering
  73. Methylation of Poloxamine for Enhanced Cell Adhesion
  74. Collagen/Poloxamine Hydrogels: Cytocompatibility of Embedded HepG2 Cells and Surface-Attached Endothelial Cells
  75. Smart Hydrogels for in Situ Generated Implants
  76. Reverse thermo-responsive poly(ethylene oxide) and poly(propylene oxide) multiblock copolymers
  77. Ethoxysilane-capped PEO–PPO–PEO triblocks: a new family of reverse thermo-responsive polymers
  78. Poly(ethylene glycol)-poly(epsilon-caprolactone) block oligomers as injectable materials
  79. Improved reverse thermo-responsive polymeric systems
  80. Crosslinkable PEO-PPO-PEO-based reverse thermo-responsive gels as potentially injectable materials
  81. ChemInform Abstract: Synthesis and Study of Reactivity in the Diels‐Alder Reaction of 3‐ Methoxycarbonylindeno(1,2‐b)pyran‐2(5H)‐ones.